Abstract:(1) miR‐431 was identified as the most significantly differentially expressed miRNA in a miRNA expression dataset (GSE93270) containing embryonic and adult mouse heart samples. (2) Overexpression of miR‐431 promoted cardiomyocyte proliferation, whereas the suppression of miR‐431 inhibited cardiomyocyte proliferation. (3) miR‐431 direct target to FBXO32 3′‐untranslated region and inhibited FBXO32 mRNA and protein expression. (4) FBXO32 is involved in the enhanced effect of miR‐431 on cardiomyocyte proliferation. Background The induction of cardiomyocyte (CM) proliferation is a promising approach for cardiac regeneration following myocardial injury. MicroRNAs (miRNAs) have been reported to regulate CM proliferation. In particular, miR‐431 expression decreases during cardiac development, according to Gene Expression Omnibus (GEO) microarray data. However, whether miR‐431 regulates CM proliferation has not been thoroughly investigated. Methods We used integrated bioinformatics analysis of GEO datasets to identify the most significantly differentially expressed miRNAs. Real‐time quantitative PCR and fluorescence in situ hybridization were performed to determine the miRNA expression patterns in hearts. Gain‐ and loss‐of‐function assays were conducted to detect the role of miRNA in CM proliferation. Additionally, we detected whether miR‐431 affected CM proliferation in a myocardial infarction model. The TargetScan, miRDB and miRWalk online databases were used to predict the potential target genes of miRNAs. Luciferase reporter assays were used to study miRNA interactions with the targeting mRNA. Results First, we found a significant reduction in miR‐431 levels during cardiac development. Then, by overexpression and inhibition of miR‐431, we demonstrated that miR‐431 promotes CM proliferation in vitro and in vivo, as determined by immunofluorescence assays of 5‐ethynyl‐2'‐deoxyuridine (EdU), pH3, Aurora B and CM count, whereas miR‐431 inhibition suppresses CM proliferation. Then, we found that miR‐431 improved cardiac function post‐myocardial infarction. In addition, we identified FBXO32 as a direct target gene of miR‐431, with FBXO32 mRNA and protein expression being suppressed by miR‐431. FBXO32 inhibited CM proliferation. Overexpression of FBXO32 blocks the enhanced effect of miR‐431 on CM proliferation, suggesting that FBXO32 is a functional target of miR‐431 during CM proliferation. Conclusion In summary, miR‐431 promotes CM proliferation by targeting FBXO32, providing a potential molecular target for preventing myocardial injury.

miRNA-204 drives cardiomyocyte proliferation via targeting Jarid2

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

miR-10a regulates proliferation of human cardiomyocyte progenitor cells by targeting GATA6.

Mir-134 Modulates The Proliferation Of Human Cardiomyocyte Progenitor Cells By Targeting Meis2

MiR‐218 Regulated Cardiomyocyte Differentiation and Migration in Mouse Embryonic Stem Cells by Targeting PDGFRα

MiR‐431 promotes cardiomyocyte proliferation by targeting FBXO32 expression

MicroRNA-204 is Required for Differentiation of Human-Derived Cardiomyocyte Progenitor Cells

mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts.

Mir-31A-5p Promotes Postnatal Cardiomyocyte Proliferation by Targeting RhoBTB1

MicroRNA-302d Promotes the Proliferation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibiting LATS2 in the Hippo Pathway.

Critical Role of Mir-130B-5p in Cardiomyocyte Proliferation and Cardiac Repair in Mice after Myocardial Infarction.

MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.

Mirna-940 Reduction Contributes to Human Tetralogy of Fallot Development.

Mir-25 Promotes Cardiomyocyte Proliferation by Targeting FBXW7.

e0205 MicroRNA regulation of cardiomyocyte lineages from bone marrowderived mesenchymal stem cells

Screening lncRNAs essential for cardiomyocyte proliferation by integrative profiling of lncRNAs and mRNAs associated with heart development

Aberrant expression of miR-29b-3p influences heart development and cardiomyocyte proliferation by targeting NOTCH2

A Key Regulator of Cardiomyocyte Transition from Proliferative to Hypertrophic Growth in the Neonatal Heart

miR-212 Promotes Cardiomyocyte Hypertrophy through Regulating Transcription Factor 7 Like 2

Cmarr/miR-540-3p Axis Promotes Cardiomyocyte Maturation Transition by Orchestrating Dtna Expression

Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.